SCHEMBL22459258

SCHEMBL22459258

C=C(COC)C(=O)OCCCc1ccc(-c2ccc(OCCOC(=O)C(=C)COC)cc2CC)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 8/20 0.41
▸ SRD5A2 P31213 1/20 0.40
▸ PTPN11 Q06124 2/20 0.38
▸ FFAR4 Q5NUL3 3/20 0.38
▸ MAPK1 P28482 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ LTB4R Q15722 2/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ SLCO1B3 Q9NPD5 1/20 0.34
▸ SLCO1B1 Q9Y6L6 1/20 0.34
▸ SLC5A1 P13866 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22459385 0.96 POLB (0.40) PPARGSRD5A2PTPN11FFAR4MAPK1
SCHEMBL22459251 0.94 THRB (0.38) PPARGSRD5A2PTPN11FFAR4MAPK1
SCHEMBL22459257 0.91 PPARG (0.36) PPARGSRD5A2PTPN11FFAR4MAPK1
SCHEMBL22459369 0.91 RARB (0.35) PPARGSRD5A2FFAR4LMNA
SCHEMBL22459840 0.89 RARB (0.34) PPARGFFAR4MEN1ALDH1A1KMT2A
SCHEMBL22459380 0.89 PPARG (0.41) PPARGPTPN11FFAR4MAPK1TSHR
SCHEMBL22459556 0.89 SRD5A2 (0.42) PPARGSRD5A2PTPN11FFAR4MAPK1
SCHEMBL22083053 0.88 PTPN11 (0.43) PPARGPTPN11MAPK1MEN1USP2
SCHEMBL22459568 0.88 PPARG (0.39) PPARGPTPN11MAPK1HSD17B10MEN1
SCHEMBL22459389 0.86 SRD5A2 (0.39) SRD5A2MAPK1TSHRRECQLHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3725764-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC Corporation (JP) 2020-10-21 — — EP disclosed
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2020-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, CCND1, CPNE4 PPARG 4176/4885SRD5A2 1354/4885PTPN11 2669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback